scorecardresearch
Add as a preferred source on Google
Monday, January 5, 2026
TopicHIV

Topic: HIV

China’s method to boost birth rates in country – adding tax to condoms

Under the revised value-added tax law, consumers will pay a 13% levy on items that had been exempted since 1993, when China enforced a strict one-child policy.

Safe access to HIV medication is wrapped in stigma. This non-profit is changing that

Getting quick access to PEP is important because the course must be started within 72 hours of a potential exposure to HIV to be effective. That's the gap the directory aims to fill.

Eliminating AIDS has been an uphill battle. But Melbourne researchers just got one step closer

Bengaluru: Eliminating AIDS is a Sisyphian challenge. Treatments mostly miss the Human Immunodeficiency Virus (HIV) that are hidden in the body. But in a...

What is Hyderabad’s role in global acetone trade? New book explores the city beyond biryani

In 'Beyond Biryani', journalist Dinesh C Sharma unpacks the city's identity beyond its clichés and stereotypes, highlighting its contributions to industrial & scientific breakthroughs.

Why Indian patients groups are opposing patent requests for blockbuster HIV drug lenacapavir

Granting patents to US firm Gilead Sciences for lenacapavir could hinder global efforts to end AIDS & restrict access to affordable generics in India, warn civil society organisations.

Meth addiction, HIV, and a struggling health system plague Fiji as tourism grows

With children as young as nine being treated for addiction, and with crime statistics and HIV and AIDS cases climbing dramatically, police have called for a state of emergency.

Llama nanobodies can target HIV-1 strains & Sun starts next solar cycle halfway throught current one

ScientiFix, our weekly feature, offers you a summary of the top global science stories of the week, with links to their sources.

Hope like never before — a drug that promises 100% protection from HIV

Lenacapavir, developed by Gilead Sciences, was tested as a pre-exposure prophylaxis in African women & is now being tested in other groups who are among the most vulnerable to HIV.

Global life expectancy on the rise — men and women to live more than 4 years longer by 2050

ScientiFix, our weekly feature, offers you a summary of the top global science stories of the week, with links to their sources.

New lead for AIDS treatment? IISER scientists identify circular RNA that helps HIV-1 virus multiply

Findings published in journal Science Advances. The scientists have also developed a protein molecule that can reduce the multiplication of the HIV virus.

On Camera

Trump is tying his legacy to whatever happens in Venezuela

A bad turn in Venezuela would raise the same questions that have dogged the unlawful US strikes against alleged drug boats in the Caribbean: Why now, and why at all?

Trump threatens India with fresh tariffs on Russian oil, calls PM Modi a ‘good guy’

The latest comment comes as New Delhi and Washington have yet to sign a trade agreement. India’s purchase of Russian oil has reduced, but Moscow remains top source for crude.

Greece looking at TATA’s WhAP infantry combat vehicle for army procurement

If deal goes through, Greece will be 2nd foreign country to procure vehicle. Morocco was first; TATA Group has set up manufacturing unit there with minimum 30 percent indigenous content.

A year-end Mea Culpa in National Interest—The Army-Islam combo doesn’t kill democracy

Many of you might think I got something so wrong in National Interest pieces written this year. I might disagree! But some deserve a Mea Culpa. I’d deal with the most recent this week.